APN 2024 - November 18-20
Dear Colleagues,
It is my great pleasure to announce the 2024 Asian Pharmacometrics Network
(APN) Workshop and Symposium, which will be held virtually on 18-20 November.
Similar to previous years, this year's symposium will feature 14 invited
speakers from various Asian countries, as well as 8 student speakers, which
will encourage the participation of future pharmacometricians.
In particular, an update from ICH-15 on the strategic role of pharmacometrics
in accelerating MIDD will be presented in the keynote session, which will
certainly enhance the core knowledge required in modern drug development for
the audience.
As usual, a pre-symposium workshop will be held on the day before the
symposium, focusing on "Handling Pharmacometrics Case Study in the Optimisation
of Drug Development and Clinical Therapy".
The workshop and symposium are free of charge and can be registered at
http://ugm.id/registerAPN, and details of the program can
be found at https://conference.farmasi.ugm.ac.id/.
For further information, please contact the local host, Dr Akhmad Kharis
Nugroho of Universitas Gadjah Mada, Indonesia, at
<[email protected]<mailto:[email protected]>>.
Best regards,
APN Chair
Kyungsoo Park
---------------------------------------
Kyungsoo Park, PhD, MD
Professor of Pharmacology
Yonsei University College of Medicine
50-1 Yonsei-Ro, Seoul 03722, Korea
Tel +82-2-2228-1735 / Fax +82-2-313-1894
Email [email protected]<mailto:[email protected]>
상기 메일은 지정된 수신인 만을 위한 것이며 부정경쟁 방지 및 영업비밀보호에 관한 법률을 포함하여 관련 법령에 따라 보호의 대상이 되는
영업비밀, 산업기술 등을 포함하고 있을 수 있습니다. 본 문서에 포함된 정보의 전부 또는 일부를 무단으로 제3자에게 공개, 배포, 복사 또는
사용하는 것은 엄격히 금지됩니다. 본 메일이 잘못 전송된 경우, 발신인에게 알려주시고 즉시 삭제하여 주시기 바랍니다. The above
message is intended solely for the named addressee and may contain trade
secret, industrial technology or privileged and confidential information
otherwise protected under applicable law including the Unfair Competition
Prevention and Trade Secret protection act. Any unauthorized dissemination,
distribution, copying or use of the information contained in this communication
is strictly prohibited. If you have received this communication in error,
please notify the sender by email and delete this communication immediately.